<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ritenbaugh, Cheryl</style></author><author><style face="normal" font="default" size="100%">Stanford, Janet L</style></author><author><style face="normal" font="default" size="100%">Wu, LieLing</style></author><author><style face="normal" font="default" size="100%">Shikany, James M</style></author><author><style face="normal" font="default" size="100%">Schoen, Robert E</style></author><author><style face="normal" font="default" size="100%">Stefanick, Marcia L</style></author><author><style face="normal" font="default" size="100%">Taylor, Vicky</style></author><author><style face="normal" font="default" size="100%">Garland, Cedric</style></author><author><style face="normal" font="default" size="100%">Frank, Gail</style></author><author><style face="normal" font="default" size="100%">Lane, Dorothy</style></author><author><style face="normal" font="default" size="100%">Mason, Ellen</style></author><author><style face="normal" font="default" size="100%">McNeeley, S Gene</style></author><author><style face="normal" font="default" size="100%">Ascensao, Joao</style></author><author><style face="normal" font="default" size="100%">Chlebowski, Rowan T</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">Women's Health Initiative Investigators</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Cancer Epidemiol. Biomarkers Prev.</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Aged</style></keyword><keyword><style  face="normal" font="default" size="100%">Colorectal Neoplasms</style></keyword><keyword><style  face="normal" font="default" size="100%">Double-Blind Method</style></keyword><keyword><style  face="normal" font="default" size="100%">Estrogens, Conjugated (USP)</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style  face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style  face="normal" font="default" size="100%">Placebos</style></keyword><keyword><style  face="normal" font="default" size="100%">Postmenopause</style></keyword><keyword><style  face="normal" font="default" size="100%">Proportional Hazards Models</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style  face="normal" font="default" size="100%">Survival Analysis</style></keyword><keyword><style  face="normal" font="default" size="100%">United States</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008 Oct</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">2609-18</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">In separate Women's Health Initiative randomized trials, combined hormone therapy with estrogen plus progestin reduced colorectal cancer incidence but estrogen alone in women with hysterectomy did not. We now analyze features of the colorectal cancers that developed and examine the survival of women following colorectal cancer diagnosis in the latter trial.</style></abstract><issue><style face="normal" font="default" size="100%">10</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/18829444?dopt=Abstract</style></custom1></record></records></xml>